
|Podcasts|April 9, 2021
Podcast: Visus presbyopia drop gets FDA IND OK
A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application
Advertisement
Rhett Schiffman, MD, MHSA, chief medical officer and head of research and development at Visus Therapeutics, talks with Gretchyn Bailey, NCLC, FAAO, editor in chief of Optometry Times® about Brimichol, the company’s presbyopia-correcting eyedrop that recently received FDA acceptance of its investigational new drug (IND) application.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
First chronic hypotony clinic established at Moorfields Eye Hospital
2
What’s new in 2025-2026: Ophthalmic drugs and drug delivery systems
3
Deseyne EDOF daily contact lenses first of its kind approved by US FDA
4
Newly revised ANSI/ISEA Z87.1-2025 clarifies standards for occupational, educational eye and face protectors
5












































